Abstract:The conversion of proteins from their native state into well-organized fibrillar aggregates, whether inside cells or in the extracellular space of connective tissue, leads to the pathogenesis of several human diseases that include neurodegenerative diseases as well as non-neuropathic conditions, such as systemic amyloidosis. Neurodegenerative diseases including Alzheimer's disease (AD) Parkinson's disease, and Huntington's disease are marked by personality changes, memory loss (dementia), cognitive changes, blurred vision, insomnia, and loss of motor control. Despite substantial advances, these disorders are usually fatal or lead- to serious debilitation and dramatic worsening of the quality of life. As a result, there is a widely appreciated need to further elucidate the pathogenesis of these diseases and to develop effective therapies. Significant progress in elucidating molecular mechanisms that trigger the aggregation and the pathogenicity of proteins has enabled the design of novel and potentially powerful treatments. Nevertheless, little is known of the critical interactions in the complex in-vivo milieu which determines where and when protein deposition occurs in individual patients. Moreover, understanding of which molecular species are responsible for pathogenesis is far from complete.14-3-3 proteins are small, conserved scaffolding molecules that are expressed in all eukaryotes. They modulate the function of other proteins, primarily in a phosphorylation-dependent manner. They are abundantly expressed in the brain and are often thought to be involved in age-related neurodegenerative diseases. To date, several hundreds of 14-3-3 binding partners have been identified. This diverse group includes protein kinases, phosphatases, receptors, transcription factors, structural and cytoskeletal proteins, as well as small G-proteins and their regulators. Consequently, 14-3-3 proteins could be promising targets for therapeutic intervention. Previous studies on invertebrates have demonstrated the importance of these proteins for regulation of synaptic function, learning and memory. Nevertheless, the exact roles of 14-3-3 proteins in neurodegenerative diseases are still unclear. The present collection of articles brings together original research, reviews, and perspectives in the biology of 14-3-3 proteins and their possible relevance for therapy of neurodegenerative disease. An article by Obsilova and Obsil (2024) describes the molecular mechanisms through which 14-3-3 proteins regulate their binding partners. These mechanisms fall into three categories: 1) direct conformational modulation of the bound partner; 2) physical occlusion of sequence-specific or structural features on the surface of the target protein; and 3) scaffolding, which facilitates protein-protein interactions (Obsilova and Obsil, 2024).Although most binding partners of 14-3-3 proteins contain phosphorylated binding motifs, these proteins can also bind to non-phosphorylated motifs with high affinity. One example of phosphorylation-independent interaction is with exoenzyme S (ExoS), a bacterial ADP-ribosyltransferase toxin of Pseudomonas aeruginosa. This interaction is essential for toxin function. Structural studies on the complex between 14-3-3ζ and the ExoS peptide, identified as an amphipathic motif, revealed that the ExoS peptide binds to 14-3-3 mainly through hydrophobic contacts (Ottmann et al., 2007a). Another well-characterized peptide, the R18 peptide, derived from a phage display library, binds 14-3-3 proteins with high affinity through an amphipathic motif (Wang et al., 1999). 14-3-3 proteins modulate the activity of many enzymes including arylalkylamine N-acetyltransferase, tyrosine hydroxylase, tryptophan hydroxylase, yeast neutral trehalase, apoptosis signal-regulating kinases, protein kinases B-RAF and C-RAF, leucine-rich repeat protein kinase-2 (LRRK2), protein kinase C (PKC), calcium/calmodulin-dependent protein kinase kinases, death-associated protein kinase 2, phosphatidylinositol-4-kinase-III, protein phosphatase CDC25C, and E3 ligase neural precursor cell expressed developmentally down-regulated 4 ligase. Interestingly,14-3-3 protein binding motifs, are often located near a nuclear localization sequence (NLS) or nuclear export sequence (NES) and can thereby modulate the subcellular localization of its target (Muslin and Xing, 2000)). A well-known example is Forkhead box O transcription factors (FOXO), which are crucial for cell survival, DNA damage repair, and stress resistance (Gui and Burgering, 2021). Other examples are Class II histone deacetylases (HDAC4 and HDAC5), whose subcellular localization is controlled in a phosphorylation-dependent and 14-3-3 dependent manner through two 14-3-3 binding motifs: a NLS located between these two motifs, and a NES at the C-terminus, which is inactive in unphosphorylated HDACs. Obsilova and Obsil (2024) and o -Abstract Truncated-

14-3-3 binding regulates Tau assembly and microtubule association

Editorial: 14-3-3 proteins: possible importance in neurodegenerative diseases

Hiding in plain sight: Complex interaction patterns between Tau and 14-3-3ζ protein variants

14-3-3ζ Participates in the Phase Separation of Phosphorylated and Glycated Tau and Modulates the Physiological and Pathological Functions of Tau

Formation of amyloid fibrils by the regulatory 14-3-3ζ protein

14-3-3Ζ Captures SET in the Cytoplasm, Mediating Tau Pathology and Cognitive Impairments

Overexpression of 14-3-3ζ Promotes Tau Phosphorylation at Ser262 and Accelerates Proteosomal Degradation of Synaptophysin in Rat Primary Hippocampal Neurons

14-3-3 proteins—a moonlight protein complex with therapeutic potential in neurological disorder: in-depth review with Alzheimer's disease

Interaction Between 14-3-3β and PrP Influences the Dimerization of 14-3-3 and Fibrillization of PrP106-126.

Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology

Phosphorylation of Tau R2 Repeat Destabilizes Its Binding to Microtubules: A Molecular Dynamics Simulation Study

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology

The role of specific phosphorylation patterns in the oligomerization of Tau-R4

Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau Protein Induce Local Conformational Changes of the C-Terminus and Modulate Tau Self-Assembly Into Fibrillar Aggregates

Zinc Binding to Tau Influences Aggregation Kinetics and Oligomer Distribution

Structural Insights into the Role of the Proline Rich Region in Tau Function

How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?

Molecular Insights into the Differential Effects of Acetylation on the Aggregation of Tau Microtubule-Binding Repeats

Single-molecule imaging of Tau reveals how phosphorylation affects its movement and confinement in living cells

Residual structure in the repeat domain of tau: echoes of microtubule binding and paired helical filament formation

Uncovering the Effect of Ps202/pt205/ps208 Triple Phosphorylations on the Conformational Features of the Key Fragment G192-T212 of Tau Protein